Andrew Von Eschenbach - Jun 3, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Director
Signature: /s/ Sean Murphy, Attorney-in-Fact for Andrew von Eschenbach
Stock symbol: TLSI
Transactions as of: Jun 3, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/5/2024, 05:34 PM
Previous filing: Aug 14, 2023
Next filing: Aug 6, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TLSI	Stock Option (right to buy)	Gift	$0	-35K	-100%	$0.00^*	0	Jun 3, 2024	Common Stock	35K	$11.34	Direct	F1, F2
transaction	TLSI	Stock Option (right to buy)	Gift	$0	+35K		$0.00	35K	Jun 3, 2024	Common Stock	35K	$11.34	The Vons Living Trust U/T/A 4/3/2024 dated 4/3/2024	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person transferred this option to The Vons Living Trust U/T/A 4/3/2024 dated 4/3/2024, Andrew von Eschenbach and Madelyn Giancaterino von Eschenbach, Co-Trustees (the "Trust") for no consideration. The Reporting Person and his spouse are co-trustees of the Trust, and the Reporting Person is the sole beneficiary of the Trust. The Reporting Person remains the beneficial owner of the securities held by the Trust.
F2	The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.

Content

The Reporting Person transferred this option to The Vons Living Trust U/T/A 4/3/2024 dated 4/3/2024, Andrew von Eschenbach and Madelyn Giancaterino von Eschenbach, Co-Trustees (the "Trust") for no consideration. The Reporting Person and his spouse are co-trustees of the Trust, and the Reporting Person is the sole beneficiary of the Trust. The Reporting Person remains the beneficial owner of the securities held by the Trust.

The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.